scispace - formally typeset
S

Stuart B. Levy

Researcher at Tufts University

Publications -  366
Citations -  36643

Stuart B. Levy is an academic researcher from Tufts University. The author has contributed to research in topics: Tetracycline & Escherichia coli. The author has an hindex of 88, co-authored 366 publications receiving 34233 citations. Previous affiliations of Stuart B. Levy include National Institutes of Health & Mayo Clinic.

Papers
More filters
Journal ArticleDOI

Antibacterial resistance worldwide: causes, challenges and responses.

TL;DR: The optimism of the early period of antimicrobial discovery has been tempered by the emergence of bacterial strains with resistance to these therapeutics, and today, clinically important bacteria are characterized not only by single drug resistance but also by multiple antibiotic resistance.
Journal ArticleDOI

Food Animals and Antimicrobials: Impacts on Human Health

TL;DR: The substantial and expanding volume of evidence reporting animal-to-human spread of resistant bacteria, including that arising from use of NTAs, supports eliminating NTA use in order to reduce the growing environmental load of resistance genes.
Journal ArticleDOI

Molecular Mechanisms of Antibacterial Multidrug Resistance

TL;DR: The intrinsic mechanisms not commonly specified by mobile elements, such as efflux pumps that expel multiple kinds of antibiotics, are now recognized as major contributors to multidrug resistance in bacteria.
Journal ArticleDOI

Triclosan targets lipid synthesis

TL;DR: It is shown that triclosan blocks lipid synthesis in Escherichia coli, and that mutations in, or overexpression of, the gene fabI (which encodes enoyl reductase, involved in fatty acid synthesis) prevents this blockage.